The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 120.00
Bid: 118.00
Ask: 122.00
Change: 7.50 (6.67%)
Spread: 4.00 (3.39%)
Open: 117.50
High: 120.50
Low: 117.50
Prev. Close: 112.50
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Joint poultry vaccine development licencing deal

19 Nov 2018 07:00

ECO Animal Health Group plc

(AIM: EAH)

ECO Animal Health and University of Georgia sign poultry vaccine development licencing deal

ECO Animal Health Ltd (ECO), a wholly owned subsidiary of ECO Animal Health Group plc, is pleased to announce that it has entered into a licensing deal with the Poultry Diagnostic & Research Center, College of Veterinary Medicine at the University of Georgia (UGA).

This deal, at a cost of just over $1 million in phased payments of eight quarterly instalments over a two year period, allows ECO to license research related innovations leading to the development of potential vaccines in the field of Mycoplasma gallisepticum, a bacterium that can cause severe respiratory disease in poultry. A joint steering committee will meet monthly to review data, monitor progress and reach go/no-go decisions.

Peter Lawrence, Chairman of ECO Animal Health Group plc said, “Mycoplasma-related illnesses in poultry can be financially devastating to commercial poultry producers with global losses estimated at more than £500 million annually. We are delighted to have entered into this collaboration with UGA and expect that further innovative developments will follow”.

Professor Naola Ferguson-Noel, a researcher in the Poultry Diagnostic & Research Center said, “Although Mycoplasma control programs are often based on biosecurity, early detection, quarantine and elimination of positive flocks, vaccination can be a very effective option in some circumstances. I do think a vaccine is within reach.”

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Contacts:

ECO Animal Health Group plc

Peter Lawrence 020 8336 6190
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
N+1 Singer (Nominated Adviser) 020 7496 3000
Mark Taylor, Brough Ransom
Peel Hunt LLP (Joint Broker)
James Steel, Dr Christopher Golden 020 7418 8900

-----------------------------------------------------

About ECO Animal Health Ltd

ECO Animal Health based in London U.K. is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. Its products for these growth markets promote well-being in animals and include the novel antimicrobial, Aivlosin®, as well as a range of generic therapeutic products.

About University of Georgia

UGA is an American public, flagship, and comprehensive research university based in Athens, Georgia. It has been ranked in the Top 10 of all USA universities for licensing deals for the past decade and, to date, more than 700 UGA products and technologies have been introduced to the marketplace.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181118005025/en/

Copyright Business Wire 2018

Date   Source Headline
23rd Apr 20153:04 pmBUSTransaction in Own Shares
15th Apr 201512:12 pmBUSIssue of Equity
14th Apr 201511:47 amBUSIssue of Equity
13th Apr 20157:00 amBUSTrading Statement
17th Mar 201510:50 amBUSTransaction in Own Shares
11th Mar 20153:43 pmBUSDirector/PDMR Shareholding - Replacement
2nd Mar 20159:37 amBUSIssue of Equity
26th Feb 20159:19 amBUSIssue of Equity
23rd Feb 20155:00 pmBUSHolding(s) in Company
18th Feb 20159:20 amBUSDirector/PDMR Shareholding
12th Feb 20153:24 pmBUSCirc re.Share buy-back programme
26th Jan 20152:03 pmBUSIssue of Equity
22nd Jan 201510:56 amBUSDirector/PDMR Shareholding
21st Jan 20159:22 amBUSHolding(s) in Company
13th Jan 20154:54 pmBUSIssue of Equity
22nd Dec 20141:26 pmBUSDirectorate Change
3rd Dec 20147:00 amBUSHalf-yearly Report
31st Oct 20149:18 amBUSHolding(s) in Company
18th Sep 201411:07 amBUSResult of AGM
29th Aug 201410:35 amBUSDirector/PDMR Shareholding
30th Jul 201410:24 amBUSCirc re.Posting of Annual Report and Notice of Meeting
28th Jul 20147:00 amBUSFinal Results
10th Jun 20147:00 amBUSChange of Nomad
13th Mar 20149:50 amBUSIssue of Equity
25th Feb 20149:06 amBUSRegulatory Approval
25th Feb 20147:00 amBUSRegulatory Application
3rd Feb 20147:00 amBUSRegulatory Approval
28th Jan 201412:45 pmBUSHolding(s) in Company
27th Jan 20147:00 amBUSRegulatory Approval
10th Dec 20137:00 amBUSHalf-yearly Report
2nd Dec 20137:00 amBUSRegulatory Approval
28th Nov 201310:23 amBUSIssue of Equity
28th Nov 20139:22 amBUSHolding(s) in Company
28th Oct 20137:00 amBUSRegulatory Approval
25th Oct 20133:03 pmBUSHolding(s) in Company
24th Oct 20133:04 pmBUSHolding(s) in Company
24th Oct 20132:57 pmBUSIssue of Equity
22nd Oct 20133:03 pmBUSResult of EGM
15th Oct 20131:29 pmBUSCirc re.Issue of Options
3rd Oct 20139:33 amBUSIssue of Equity
25th Sep 201312:38 pmBUSHolding(s) in Company
19th Sep 201311:28 amBUSCirc re. Scrip dividend scheme
6th Sep 20134:16 pmBUSIssue of Equity
28th Aug 201310:09 amBUSCirc re. Issue of options
25th Jul 201311:45 amBUSCirc re.Annual Report and Accounts 2013
12th Jul 20137:00 amBUSFinal Results
26th Apr 20133:47 pmBUSIssue of Equity
5th Mar 20139:36 amBUSIssue of Equity
15th Jan 201312:15 pmBUSIssue of Equity
12th Dec 20127:00 amBUSHalf-yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.